From crystal structure to in silico epitope discovery in the Burkholderia pseudomallei flagellar hook-associated

Louise J Gourlay1, Rachael J Thomas, Claudio Peri

  • 1Department of Biosciences, University of Milan, Italy.

The FEBS Journal
|February 4, 2015
PubMed

Insights

This study reveals the 3D structure of Burkholderia pseudomallei flagellar hook-associated protein (FlgK(Bp)), identifying key antigenic regions. These findings suggest FlgK(Bp) is a promising candidate for developing a melioidosis vaccine.

Area of Science:

  • Structural biology
  • Bacteriology
  • Immunology

Background:

  • Melioidosis, caused by Burkholderia pseudomallei, is a severe infection prevalent in Southeast Asia and Australia, inadequately treated by antibiotics.
  • Flagellar proteins, including FlgK(Bp), are crucial for bacterial motility, host colonization, and virulence, making them targets for vaccine development.

Purpose of the Study:

  • To elucidate the 3D structure of B. pseudomallei FlgK(Bp) for structure-based antigen engineering.
  • To investigate the antigenic properties and pathogenic role of FlgK(Bp) for potential vaccine design.

Main Methods:

  • X-ray crystallography to determine the 1.8-Å resolution structure of FlgK(Bp).
  • Analysis of immune serum from melioidosis patients and healthy subjects.
  • Assessment of FlgK(Bp) cytotoxicity on murine macrophages.
  • Computational epitope prediction and in vitro mapping.

Main Results:

  • The FlgK(Bp) structure reveals a multidomain fold with an elongated α-helical bundle core, similar to flagellin.
  • Recovered melioidosis patients exhibit higher antibody levels against FlgK(Bp).
  • FlgK(Bp) demonstrates cytotoxic effects on macrophages, indicating a role in pathogenesis.
  • Three distinct antigenic regions on FlgK(Bp) were identified through computational and experimental methods.

Conclusions:

  • FlgK(Bp) possesses a conserved structural scaffold with potential antigenic sites.
  • FlgK(Bp) contributes to B. pseudomallei pathogenesis and elicits an immune response in infected individuals.
  • FlgK(Bp) is a viable candidate for developing subunit-based melioidosis vaccines targeting specific epitopes.

Related Concept Videos